Structures by: Kaur M.
Total: 167
7-Chloro-3-(4-methylphenylsulfonyl)pyrrolo[1,2-<i>c</i>]pyrimidine
C14H11ClN2O2S
IUCrData (2020) 5, 3
a=7.2285(5)Å b=7.2385(5)Å c=13.7586(11)Å
α=102.192(7)° β=99.616(6)° γ=104.149(6)°
2-Amino-4-(4-methoxyphenyl)-1-(4-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile
C24H23N3O2
IUCrData (2018) 3, 2 x180167
a=9.1066(4)Å b=19.6406(9)Å c=11.2901(5)Å
α=90° β=94.343(4)° γ=90°
7-Bromo-1,4-bis(prop-2-ynyl)pyrido[2,3-<i>b</i>]pyrazine-2,3(1<i>H</i>,4<i>H</i>)-dione
C13H8BrN3O2
IUCrData (2018) 3, 2 x180266
a=10.1922(5)Å b=17.3470(10)Å c=7.0216(4)Å
α=90° β=92.382(5)° γ=90°
1-[(1-Butyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-3-methylquinoxalin-2(1<i>H</i>)-one
C16H19N5O
IUCrData (2018) 3, 4 x180482
a=15.8299(8)Å b=10.6270(4)Å c=9.2041(3)Å
α=90° β=98.084(4)° γ=90°
5,7,12,14-Tetrahydro-5,14:7,12-bis([1,2]benzeno)pentacene-6,13-diol dimethylformamide disolvate
C34H22O2,2(C3H7NO)
IUCrData (2016) 1, 7 x161130
a=9.3621(2)Å b=11.3559(2)Å c=15.1920(3)Å
α=90° β=98.0838(18)° γ=90°
3-(9<i>H</i>-Carbazol-9-yl)propanoic acid
C15H13NO2
IUCrData (2016) 1, 11 x161787
a=9.4550(5)Å b=11.9077(6)Å c=12.2120(7)Å
α=62.429(5)° β=79.276(4)° γ=77.627(4)°
6-Amino-3-methyl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyrazine-5-carboxamide
C13H12N6O
IUCrData (2016) 1, 11 x161742
a=14.7907(5)Å b=4.80351(15)Å c=17.1203(8)Å
α=90° β=92.067(4)° γ=90°
Ethyl 3-amino-2-carbamoyl-4-(4-methoxyphenyl)-6-methylthieno[2,3-<i>b</i>]pyridine-5-carboxylate dimethyl sulfoxide monosolvate
C19H19N3O4S,C2H6OS
IUCrData (2016) 1, 9 x161474
a=9.9950(7)Å b=10.1492(5)Å c=11.2620(8)Å
α=90.656(5)° β=92.291(5)° γ=101.925(5)°
3-Chloro-<i>r</i>-2,<i>c</i>-6-bis(4-fluorophenyl)-3-methylpiperidin-4-one
C18H16ClF2NO
IUCrData (2016) 1, 10 x161580
a=6.2844(2)Å b=11.7141(5)Å c=21.6006(10)Å
α=90° β=90° γ=90°
1-(4-Nitrophenyl)-2-({4-phenyl-5-[(<i>p</i>-tolyloxy)methyl]-4<i>H</i>-1,2,4-triazol-3-yl}sulfanyl)acetamide
C24H21N5O4S
IUCrData (2016) 1, 10 x161533
a=8.2241(4)Å b=12.2161(7)Å c=12.3952(8)Å
α=115.507(6)° β=93.532(4)° γ=96.914(4)°
2,3-dihydro-1<i>H</i>-cyclopenta[<i>b</i>]indole-4-carboxylic acid <i>tert</i>-butyl ester
C16H19NO2
IUCrData (2016) 1, 9 x161468
a=19.6761(11)Å b=7.2330(4)Å c=9.9258(7)Å
α=90° β=90° γ=90°
Ethyl {[5-acetyl-3-cyano-4-(4-methoxyphenyl)-6-methylpyridin-2-yl]sulfanyl}acetate
C20H20N2O4S
IUCrData (2016) 1, 11 x161715
a=13.4883(2)Å b=8.23273(16)Å c=16.8923(3)Å
α=90° β=93.8000(17)° γ=90°
6-Chloro-1,4-diethylquinoxaline-2,3(1<i>H</i>,4<i>H</i>)-dione
C12H13ClN2O2
IUCrData (2017) 2, 7 x171052
a=14.6454(8)Å b=12.0415(5)Å c=15.1149(9)Å
α=90° β=115.621(7)° γ=90°
(<i>Z</i>)-2-Benzylidene-3-<i>n</i>-butoxy-2<i>H</i>-1,4-benzothiazine
C19H19NOS
IUCrData (2017) 2, 6 x170890
a=7.7711(6)Å b=10.9897(11)Å c=11.4090(11)Å
α=112.013(9)° β=109.259(8)° γ=98.120(7)°
(<i>Z</i>)-4-<i>n</i>-Butyl-2-(4-chlorobenzylidene)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C19H18ClNOS
IUCrData (2017) 2, 6 x170870
a=8.8898(8)Å b=8.9885(9)Å c=12.1973(10)Å
α=89.908(8)° β=84.490(7)° γ=63.534(9)°
3-Chloro-1-ethyl-6-nitro-1<i>H</i>-indazole
C9H8ClN3O2
IUCrData (2017) 2, 7 x170972
a=7.4984(3)Å b=16.2805(7)Å c=8.3363(3)Å
α=90° β=97.403(4)° γ=90°
1,4-Dibenzyl-6-chloroquinoxaline-2,3(1<i>H</i>,4<i>H</i>)-dione
C22H17ClN2O2
IUCrData (2017) 2, 6 x170901
a=29.2234(4)Å b=8.3076(2)Å c=31.0407(5)Å
α=90° β=101.859(2)° γ=90°
6-Bromo-2-(4-methoxyphenyl)-3-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C14H12BrN3O
IUCrData (2017) 2, 7 x171071
a=14.8643(6)Å b=7.6795(4)Å c=12.0690(5)Å
α=90° β=108.465(4)° γ=90°
Prop-2-ynyl 2-oxo-1-(prop-2-ynyl)-1,2-dihydroquinoline-4-carboxylate
C16H11NO3
IUCrData (2017) 2, 7 x171072
a=7.3070(11)Å b=8.7763(13)Å c=11.2927(13)Å
α=91.059(11)° β=107.867(12)° γ=109.814(14)°
Ethyl 1-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C13H13NO3
IUCrData (2017) 2, 6 x170917
a=12.2269(4)Å b=6.7034(3)Å c=14.0817(5)Å
α=90° β=90° γ=90°
(<i>Z</i>)-2-(2-Chlorobenzylidene)-4-(prop-2-ynyl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C18H12ClNOS
IUCrData (2017) 2, 6 x170889
a=13.3937(8)Å b=8.9106(4)Å c=13.3940(7)Å
α=90° β=99.765(5)° γ=90°
4-Benzyl-6-bromo-2-(4-chlorophenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C19H13BrClN3
IUCrData (2017) 2, 6 x170899
a=8.7749(7)Å b=9.9403(7)Å c=10.4475(8)Å
α=76.030(6)° β=66.511(7)° γ=85.843(6)°
Ethyl 8-amino-7-(furan-2-yl)-5,6-dihydrothieno[2,3-<i>b</i>]benzo[<i>h</i>]quinoline-9-carboxylate
C22H18N2O3S
IUCrData (2016) 1, 11 x161884
a=11.52270(10)Å b=25.5293(3)Å c=12.47490(10)Å
α=90° β=90.0380(10)° γ=90°
Ethyl 4-(4-hydroxyphenyl) -6-(6-methoxy-2-naphthyl)-2-oxocyclohex -3-ene-1-carboxylate
C26H24O5
Crystals (2012) 2, 3 1239-1247
a=25.4114(5)Å b=8.47440(10)Å c=20.6921(4)Å
α=90.00° β=108.328(2)° γ=90.00°
C21H16N4OS,H2O
C21H16N4OS,H2O
RSC Advances (2020) 10, 35 20837-20851
a=6.9104(3)Å b=19.6432(7)Å c=14.0505(5)Å
α=90° β=100.235(4)° γ=90°
RS-AR-9
C68H56Br2Cu2N6P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=10.6202(6)Å b=11.2960(5)Å c=13.7122(7)Å
α=72.604(4)° β=70.354(5)° γ=75.461(4)°
C70H60Ag2Cl2N6P2S2
C70H60Ag2Cl2N6P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=10.4921(7)Å b=12.0020(6)Å c=13.8200(10)Å
α=82.287(5)° β=79.882(6)° γ=75.133(5)°
RS-AR-12
C68H56Ag2Br2N6P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=10.7478(4)Å b=11.3867(4)Å c=13.6861(7)Å
α=72.548(4)° β=72.022(4)° γ=75.693(3)°
C53H45CuN3P2S2
C53H45CuN3P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=9.3567(3)Å b=13.0349(4)Å c=19.9282(7)Å
α=87.801(3)° β=83.782(3)° γ=84.846(2)°
C42H42ClCuN2P2S
C42H42ClCuN2P2S
New Journal of Chemistry (2018) 42, 12 9886
a=13.0220(4)Å b=20.5063(5)Å c=14.8412(5)Å
α=90° β=105.560(4)° γ=90°
C48H54Br2Cu2N4P2S2
C48H54Br2Cu2N4P2S2
New Journal of Chemistry (2018) 42, 12 9886
a=9.4815(6)Å b=10.3547(6)Å c=13.2247(8)Å
α=79.062(5)° β=73.412(6)° γ=70.630(5)°
C54H50Br2Cu2N4P2S2
C54H50Br2Cu2N4P2S2
New Journal of Chemistry (2018) 42, 12 9886
a=10.5137(3)Å b=20.7529(6)Å c=11.7654(3)Å
α=90° β=103.798(3)° γ=90°
C43H44ClCuN2P2S
C43H44ClCuN2P2S
New Journal of Chemistry (2018) 42, 12 9886
a=13.0881(4)Å b=20.2471(5)Å c=15.2533(4)Å
α=90° β=105.139(3)° γ=90°
C46H50Br2Cu2N4P2S2
C46H50Br2Cu2N4P2S2
New Journal of Chemistry (2018) 42, 12 9886
a=9.1793(5)Å b=10.2484(7)Å c=13.4319(9)Å
α=79.123(6)° β=73.321(5)° γ=69.953(6)°
C42H42BrCuN2P2S
C42H42BrCuN2P2S
New Journal of Chemistry (2018) 42, 12 9886
a=13.0009(2)Å b=20.8461(4)Å c=14.7070(3)Å
α=90° β=105.105(2)° γ=90°
C48H54Cu2I2N4P2S2
C48H54Cu2I2N4P2S2
New Journal of Chemistry (2018) 42, 12 9886
a=9.6418(12)Å b=10.5247(8)Å c=13.4048(12)Å
α=79.580(7)° β=72.802(9)° γ=70.907(9)°
C48H54Cl2Cu2N4P2S2
C48H54Cl2Cu2N4P2S2
New Journal of Chemistry (2018) 42, 12 9886
a=9.4283(5)Å b=10.2759(7)Å c=13.1681(10)Å
α=78.871(6)° β=73.632(5)° γ=70.704(5)°
C54H50Cu2I2N4P2S2
C54H50Cu2I2N4P2S2
New Journal of Chemistry (2018) 42, 12 9886
a=10.7515(2)Å b=20.6834(4)Å c=11.9733(3)Å
α=90° β=106.826(2)° γ=90°
C45H40CuIN2P2S
C45H40CuIN2P2S
New Journal of Chemistry (2018) 42, 12 9886
a=10.5257(4)Å b=12.8802(5)Å c=15.7569(5)Å
α=76.632(3)° β=79.082(3)° γ=79.691(3)°
C43H44CuIN2P2S
C43H44CuIN2P2S
New Journal of Chemistry (2018) 42, 12 9886
a=12.8975(3)Å b=21.2368(4)Å c=15.1545(3)Å
α=90° β=105.562(2)° γ=90°
C30H44AuF6N4PS
C30H44AuF6N4PS
New Journal of Chemistry (2019) 43, 36 14565
a=8.6566(2)Å b=23.5651(9)Å c=17.3653(5)Å
α=90° β=98.966(2)° γ=90°
C28H40AuF6N4PS
C28H40AuF6N4PS
New Journal of Chemistry (2019) 43, 36 14565
a=9.2495(8)Å b=15.4744(14)Å c=23.370(2)Å
α=90° β=96.419(2)° γ=90°
C42H39AgN3O3P2S
C42H39AgN3O3P2S
RSC Advances (2019) 9, 27 15470
a=10.5641(6)Å b=12.9718(7)Å c=15.3593(8)Å
α=77.698(4)° β=82.402(4)° γ=79.796(4)°
C40H33AgN2P2S,CH4O
C40H33AgN2P2S,CH4O
RSC Advances (2019) 9, 27 15470
a=10.1240(4)Å b=13.4635(6)Å c=14.1829(6)Å
α=77.466(4)° β=78.784(4)° γ=78.993(4)°
C41H34AgN4P2S,NO3
C41H34AgN4P2S,NO3
RSC Advances (2019) 9, 27 15470
a=9.2210(3)Å b=25.4962(8)Å c=17.0609(5)Å
α=90° β=100.830(3)° γ=90°
C40H34AgN2OP2S,NO3,H2O
C40H34AgN2OP2S,NO3,H2O
RSC Advances (2019) 9, 27 15470
a=12.5062(7)Å b=13.1744(7)Å c=15.1280(7)Å
α=99.534(4)° β=103.826(5)° γ=114.897(5)°
C43H44AgN3O3P2S
C43H44AgN3O3P2S
RSC Advances (2019) 9, 27 15470
a=13.6628(4)Å b=16.2436(5)Å c=18.8410(6)Å
α=90° β=105.902(3)° γ=90°
C17H13FeNS
C17H13FeNS
Journal of Materials Chemistry (2012) 22, 21 10597
a=5.78750(10)Å b=25.3720(5)Å c=9.6688(2)Å
α=90.00° β=103.188(2)° γ=90.00°
C23H22FeN2
C23H22FeN2
Journal of Materials Chemistry (2012) 22, 21 10597
a=7.3555(4)Å b=11.6373(7)Å c=11.6538(6)Å
α=85.685(4)° β=81.702(4)° γ=75.203(5)°
C36H35BrCuN4PS2
C36H35BrCuN4PS2
New Journal of Chemistry (2018) 42, 12 9886
a=9.9322(4)Å b=10.6993(4)Å c=17.6677(8)Å
α=76.569(3)° β=80.316(4)° γ=69.508(4)°
C60H52Ag2N8P4S2,2(NO3),2(H2O)
C60H52Ag2N8P4S2,2(NO3),2(H2O)
RSC Advances (2019) 9, 27 15470
a=25.2895(7)Å b=13.2208(2)Å c=23.5888(7)Å
α=90° β=125.671(4)° γ=90°
C12H24ClCuN4S2
C12H24ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=14.0097(4)Å b=14.0814(3)Å c=18.9263(6)Å
α=90° β=108.984(3)° γ=90°
C42H79.76Cl6Cu6N12S6
C42H79.76Cl6Cu6N12S6
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=17.5632(7)Å b=17.5632(7)Å c=17.7092(9)Å
α=90° β=90° γ=120°
C54H60Cu4I4N12S6
C54H60Cu4I4N12S6
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=9.573(4)Å b=10.198(5)Å c=16.821(8)Å
α=100.18(2)° β=99.48(3)° γ=98.79(3)°
C10H20CuIN4S2
C10H20CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=8.6359(7)Å b=7.3154(5)Å c=26.7530(18)Å
α=90.00° β=95.591(3)° γ=90.00°
C18H20ClCuN4S2
C18H20ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.5161(5)Å b=10.4367(5)Å c=28.1083(14)Å
α=90° β=92.378(5)° γ=90°
C8H16ClCuN4S2
C8H16ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=12.9744(16)Å b=7.6298(10)Å c=14.1661(16)Å
α=90° β=105.936(13)° γ=90°
C20H36Cu5I6N8S2
C20H36Cu5I6N8S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=8.0690(4)Å b=9.9078(6)Å c=13.1167(8)Å
α=99.126(5)° β=102.165(5)° γ=111.425(5)°
C36H40Br2Cu2N8S4
C36H40Br2Cu2N8S4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=15.6581(17)Å b=12.6438(15)Å c=19.708(2)Å
α=90.00° β=94.694(4)° γ=90.00°
C9H10CuIN2S
C9H10CuIN2S
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=15.6938(9)Å b=12.7042(6)Å c=11.1498(6)Å
α=90° β=95.604(5)° γ=90°
C8H16BrCuN4S2
C8H16BrCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.2573(9)Å b=7.4836(5)Å c=14.3879(10)Å
α=90° β=107.330(7)° γ=90°
C8H16CuIN4S2
C8H16CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.710(3)Å b=7.422(4)Å c=14.723(2)Å
α=90.00° β=109.448(5)° γ=90.00°
JPL-212
C14H28BrCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=7.3515(4)Å b=10.0895(5)Å c=14.3386(6)Å
α=102.109(4)° β=101.930(4)° γ=100.673(4)°
<i>O</i>,<i>O</i>'-Dimethyl [(2,3,4,5,6-pentafluorophenylhydrazinyl]phosphonate
C8H8F5N2O3P
Acta Crystallographica Section C (2019) 75, 10
a=10.5273(2)Å b=10.3266(3)Å c=21.1193(5)Å
α=90° β=92.647(2)° γ=90°
(<i>E</i>)-4-Bromo-2-[(2-hydroxyphenylimino)methyl]-6-methoxyphenol
C14H12BrNO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=13.297(2)Å b=15.095(3)Å c=6.4166(13)Å
α=90° β=91.329(6)° γ=90°
(<i>E</i>)-4-Bromo-2-methoxy-6-[(2-methoxyphenylimino)methyl]phenol
C15H14BrNO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=6.4158(3)Å b=7.3886(4)Å c=15.2636(7)Å
α=87.081(3)° β=87.488(3)° γ=77.948(3)°
(<i>E</i>)-<i>N</i>-(3,4-Dimethylisoxazol-5-yl)-4-[(2-hydroxybenzylidene)amino]benzenesulfonamide
C18H17N3O4S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=20.344(2)Å b=9.6384(9)Å c=9.4430(10)Å
α=90° β=101.060(3)° γ=90°
(<i>E</i>)-4-[(5-Bromo-2-hydroxy-3-methoxybenzylidene)amino]-<i>N</i>-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
C19H18BrN3O5S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=13.6043(11)Å b=12.2399(7)Å c=12.9506(9)Å
α=90° β=103.854(2)° γ=90°
(<i>E</i>)-2-Methoxy-6-[(2-methoxyphenylimino)methyl]phenol
C15H15NO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=23.689(2)Å b=7.6951(7)Å c=7.3488(7)Å
α=90° β=90° γ=90°
(<i>E</i>)-3-Benzoyl-2-[(2-hydroxybenzylidene)amino)]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C22H19NO2S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.26395(15)Å b=14.2886(2)Å c=13.6476(2)Å
α=90° β=96.7581(15)° γ=90°
(<i>E</i>)-3-Benzoyl-2-[(5-fluoro-2-hydroxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C22H18FNO2S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.5004(8)Å b=14.2911(11)Å c=13.6497(9)Å
α=90° β=97.524(2)° γ=90°
(<i>E</i>)-[(2-Hydroxyphenylimino)methyl]phenol
C13H11NO2
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.0479(7)Å b=10.1564(8)Å c=12.3659(10)Å
α=69.677(6)° β=89.940(6)° γ=77.004(6)°
1-(4-Methylphenyl)-4,9-dihydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C17H15N3
Acta Crystallographica Section C (2016) 72, 9
a=6.6676(17)Å b=26.571(8)Å c=7.912(2)Å
α=90° β=104.561(9)° γ=90°
(<i>E</i>)-1-[(2-Chloroquinolin-3-yl)methylidene]-2-(4-methylphenyl)hydrazine
C17H14ClN3
Acta Crystallographica Section C (2016) 72, 9
a=14.730(6)Å b=12.413(5)Å c=16.464(5)Å
α=90° β=90° γ=90°
6-Methyl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C17H13N3
Acta Crystallographica Section C (2016) 72, 9
a=29.9202(12)Å b=29.9202(12)Å c=7.3811(3)Å
α=90° β=90° γ=120°
1-Phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C16H11N3
Acta Crystallographica Section C (2016) 72, 9
a=25.145(2)Å b=16.9623(19)Å c=16.8138(19)Å
α=90° β=90° γ=90°
3-Butyl-2,6-bis(4-fluorophenyl)piperidin-4-one
C21H23F2NO
Acta Crystallographica Section E (2020) 76, 5 651-655
a=5.4945(3)Å b=25.0707(13)Å c=12.9811(9)Å
α=90° β=93.497(6)° γ=90°
Ethyl 2-{4-[(2-ethoxy-2-oxoethyl)(phenyl)carbamoyl]-2-oxo-1,2-\ dihydroquinolin-1-yl}acetate
C24H24N2O6
Acta Crystallographica Section E (2019) 75, 11 1753-1758
a=16.9368(5)Å b=15.4130(4)Å c=18.4562(6)Å
α=90° β=109.254(4)° γ=90°
(Acetonitrile)[2-methoxy-<i>N</i>,<i>N</i>-bis(quinolin-2-ylmethyl)ethylamine]copper(II) bis(perchlorate)
C25H26CuN4O,2(ClO4)
Acta Crystallographica Section E (2018) 74, 8 1138-1141
a=11.3597(3)Å b=16.9611(4)Å c=14.5514(3)Å
α=90° β=95.622(2)° γ=90°
(Acetato-κ^2^<i>O</i>,<i>O</i>)(methanol-κ<i>O</i>)[tris(pyridin-2-ylmethyl)amine-κ^4^<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>''']manganese(II) tetraphenylborate
C21H25MnN4O3,C24H20B
Acta Crystallographica Section E (2018) 74, 8 1075-1078
a=11.3885(8)Å b=11.7598(7)Å c=15.6703(10)Å
α=82.041(5)° β=70.671(6)° γ=85.870(5)°
Clozapinium 3,5-dinitrobenzoate dimethyl sulfoxide monosolvate
C18H20ClN4,C7H3N2O6,C2H6OS
Acta Crystallographica Section E (2015) 71, 4 406-413
a=15.3593(2)Å b=15.7685(2)Å c=11.8679(2)Å
α=90° β=91.8097(14)° γ=90°
Clozapinium hydrogen maleate 0.21-hydrate
C18H20ClN4,C4H3O4,0.21(H2O)
Acta Crystallographica Section E (2015) 71, 4 406-413
a=9.7166(3)Å b=9.9699(2)Å c=23.1059(6)Å
α=90° β=96.800(3)° γ=90°
Clozapinium 2-hydroxybenzoate
C18H20ClN4,C7H5O3
Acta Crystallographica Section E (2015) 71, 4 406-413
a=17.4296(5)Å b=15.3728(5)Å c=8.6359(3)Å
α=90° β=90.325(3)° γ=90°
Nonacyclo[14.6.6.6^5,12^.0^2,15^.0^4,13^.0^6,11^.0^17,22^.0^23,28^.0^29,34^]tetratriaconta-2(15),4(13),6,8,10,17,19,21,23,25,27,29(34),30,32-tetradecaene-3,14-dione
C34H20O2
Acta Crystallographica Section E (2016) 72, 12 1734-1738
a=10.3419(4)Å b=11.7885(6)Å c=19.2267(11)Å
α=77.606(5)° β=89.306(4)° γ=86.658(4)°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C18H18ClNO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=6.7150(6)Å b=10.9591(13)Å c=11.1704(10)Å
α=72.162(9)° β=79.721(7)° γ=76.873(8)°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-di-<i>p</i>-tolylpiperidin-4-one
C20H22ClNO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=13.0578(2)Å b=22.6513(4)Å c=5.93756(8)Å
α=90° β=90° γ=90°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-bis(4-chlorophenyl)piperidin-4-one
C18H16Cl3NO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=13.2430(4)Å b=22.3945(6)Å c=5.81947(14)Å
α=90° β=90° γ=90°
3-(2-Chloroethyl)-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C19H20ClNO
Acta Crystallographica Section E (2018) 74, 4 483-486
a=11.3306(3)Å b=13.3638(4)Å c=10.9821(3)Å
α=90° β=91.996(2)° γ=90°
3-(2-chloroethyl)-<i>r</i>-2,<i>c</i>-6-bis(4-fluorophenyl)piperidin-4-one
C19H18ClF2NO
Acta Crystallographica Section E (2018) 74, 4 483-486
a=5.5105(2)Å b=24.2612(6)Å c=12.8622(3)Å
α=90° β=93.809(3)° γ=90°
3-(4,4-Dimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-ylidene)-6-methyl-3,4-dihydro-2<i>H</i>-pyran-2,4-dione
C17H18N2O3
Acta Crystallographica Section E (2019) 75, 2 228-232
a=5.53730(10)Å b=24.0197(4)Å c=11.7815(3)Å
α=90° β=103.488(2)° γ=90°
3-Benzoyl-2-[(5-bromo-2-hydroxy-3-methoxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C23H20BrNO3S
Acta Crystallographica Section E (2015) 71, 2 176-179
a=4.81267(18)Å b=22.1919(8)Å c=18.7012(7)Å
α=90° β=97.392(3)° γ=90°
Bis-[1-(3-chlorophenyl)piperazinium]dipicrate picric acid
2(C10H14ClN2),2(C6H2N3O7),C6H3N3O7
Acta Crystallographica Section E (2014) 70, 11 o1210-o1211
a=11.2213(6)Å b=14.6239(7)Å c=14.1804(8)Å
α=90° β=104.405(5)° γ=90°
9-[3-(Dimethylamino)propyl]-10,10-dimethyl-9,10-dihydroanthracen-9-ol
C21H27NO
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o175
a=11.79596(9)Å b=9.17559(7)Å c=16.75788(13)Å
α=90° β=92.2372(7)° γ=90°
6-(2-Chlorophenyl)-2-methylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C11H8ClN3S
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=7.5567(3)Å b=11.4589(5)Å c=24.9006(11)Å
α=90° β=90° γ=90°
6-(2-Chlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C10H6ClN3S
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=7.5805(4)Å b=9.7942(5)Å c=13.6175(6)Å
α=97.712(2)° β=96.549(2)° γ=99.416(2)°
6-(3,4-Dichlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C10H5Cl2N3S
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=5.5186(2)Å b=7.5194(3)Å c=12.8406(5)Å
α=102.027(2)° β=91.293(2)° γ=98.430(2)°
6-(4-Fluoro-3-methoxyphenyl)-2-methylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C12H10FN3OS
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=8.6766(3)Å b=11.7888(4)Å c=12.5227(4)Å
α=103.039(2)° β=95.189(2)° γ=110.365(2)°
<i>N</i>-(4-Chloro-3-methylphenyl)-2-phenylacetamide
C15H14ClNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=5.0039(7)Å b=10.7525(12)Å c=12.6177(12)Å
α=108.615(10)° β=91.771(11)° γ=90.167(11)°
<i>N</i>-(4-Chloro-3-methylphenyl)-2-(2,4-dichlorophenyl)acetamide
C15H12Cl3NO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=11.8441(7)Å b=4.7288(3)Å c=13.0981(7)Å
α=90° β=101.310(6)° γ=90°
<i>N</i>-(4-Bromo-3-methylphenyl)-2-phenylacetamide
C15H14BrNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=4.9995(3)Å b=10.8392(4)Å c=12.7301(7)Å
α=108.149(4)° β=91.968(5)° γ=90.310(4)°